Peter Ganz, MD
Enriched profileProfessor of Medicine, Director of the Center of Excellence in Vascular Research at Zuckerberg San Francisco General Hospital · University of California, San Francisco
Peter Ganz is Professor of Medicine, Director of the Center of Excellence in Vascular Research at Zuckerberg San Francisco General Hospital at University of California, San Francisco. OpenAlex indexes 519 publications with 43,068 citations (h-index 98); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 22 Oct 2026
Peter Ganz, MD, is Professor of Medicine, Director of the Center of Excellence in Vascular Research at Zuckerberg San Francisco General Hospital at University of California, San Francisco. The public record shows 519 publications with 43,068 citations (h-index 98), centered on Nitric Oxide and Endothelin Effects, Cardiovascular Health and Disease Prevention, Coronary Interventions and Diagnostics. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 4 companies, 6 NIH-funded awards (2013–2024).
- Most recent indexed publication: 2026 · Journal of the American Society of Nephrology
- Top research focus: Nitric Oxide and Endothelin Effects
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 35 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 262.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Cardiovascular Assessment of the Effects of Tobacco and Nicotine Delivery Products
Sponsor: University of California, San Francisco
- Dose-dependent Effects of Second-hand Smoke on Vascular Function
Sponsor: University of California, San Francisco
Industry payments
Updated 22 Oct 2026
4 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20241 payment
- Amgen Inc.Program year20231 payment
- AstraZeneca UK LimitedProgram year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
65.1%Angiotensin receptor blocker (ARB)21.7%Losartan Potassium100%Part D≥13 patientsStatin15.7%Atorvastatin Calcium100%Part D≥11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
19.3%SGLT2 inhibitor19.3%Jardiance100%Part D≥14 patientsBlood & clotting
15.7%P2Y12 inhibitor15.7%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
6 NIH research awards on record, funded 2013–2024 per NIH RePORTER. The latest:
- Integrating Large-Scale Proteomics and Genomics for the Biological Characterization of Ischemic Stroke in REGARDS
University of Pennsylvania
FY2026$703,249R01NS141408 - Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics
Ut Southwestern Medical Center
FY2024$732,468R01HL153499 - Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis
University of California, San Francisco
FY2024$569,975R01HL159081
Congress activity
Updated 22 Oct 2026
3 congress contributions (2022–2026) across AACR per OpenAlex. The most recent:
- Abstract 6320: Plasma proteomics of cancer risk in patients with chronic kidney disease
AACR Annual Meeting
AACR2026Co-author - Abstract LB515: Cardiovascular risk assessed by aptamer-based proteomics is increased in early breast cancer
AACR (meeting unresolved)
AACR2022Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Authors' Reply: Kidney Risk Strata and Proteomic Prediction of Atrial Fibrillation in CKD.
Journal of the American Society of Nephrology
Article2026 - Integrating Genomics and Proteomics to Identify Causal Proteins and Biologic Pathways for Incident Atrial Fibrillation in CKD.
Journal of the American Society of Nephrology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Role of Endothelial Dysfunction in AtherosclerosisArticle2,515 citations2004
- 02Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesArticle2,425 citations1986
- 03
- 04Close relation of endothelial function in the human coronary and peripheral circulationsArticle2,035 citations1995
- 05Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery DiseaseArticle1,326 citations2005
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 22 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/peter-ganz-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsf.edu ↗
Editorial & leadership roles
journal and society appointments- Advisory Board Member
SeeMedX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biospace.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →conductscience.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsf.edu ↗
Media & interviews
press, podcasts and appearances- Cardiology Grand Rounds speaker
UCSF: Transforming Health Care through Proteomics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsf.edu ↗ - Session Chair
PMWC (Precision Medicine World Conference)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →past.pmwcintl.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Adil Daud, MD
University of California, San Francisco
Emmanuelle Waubant, MD
University of California, San Francisco
Joel Palefsky, MD
University of California, San Francisco
Laura Esserman, MD
University of California, San Francisco
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Richard Mayeux, MD
Columbia University College of Physicians and Surgeons